Volume 56, Issue 5, Pages 1920-1927 (November 1999) Sharing cross-reactive groups of MHC class I improves long-term graft survival Yvo W.J. Sijpkens, M.D., Ilias I.N. Doxiadis, Johan W. de Fijter, Marko J.K. Mallat, Leendert A. van Es, Peter de Lange, Aeilko H. Zwinderman, Rudi G.J. Westendorp, Folkert J. van Kemenade, Jan-Anthonie Bruijn, Frans H.J. Claas, Leendert C. Paul Kidney International Volume 56, Issue 5, Pages 1920-1927 (November 1999) DOI: 10.1046/j.1523-1755.1999.00753.x Copyright © 1999 International Society of Nephrology Terms and Conditions
Figure 1 Graft survival and cross-reactive antigen (CREG) sharing. Kaplan–Meier estimates for transplants sharing 4 to 8 CREG (solid line, N = 516) and sharing 1 to 3 CREG (dashed line, N = 126). Log-rank test, P = 0.0011. Kidney International 1999 56, 1920-1927DOI: (10.1046/j.1523-1755.1999.00753.x) Copyright © 1999 International Society of Nephrology Terms and Conditions
Figure 2 Graft survival and acute rejection type. Kaplan–Meier estimates for transplants without rejection (solid line, N = 292), interstitial rejection (dash dot dash line, N = 222) and vascular rejection (dashed line, N = 95) within six-months post-transplant. Log-rank test, P = 0.0026, interstitial vs. no rejection; P < 0.001 vascular vs. no rejection; P = 0.0038, vascular vs. interstitial rejection. Kidney International 1999 56, 1920-1927DOI: (10.1046/j.1523-1755.1999.00753.x) Copyright © 1999 International Society of Nephrology Terms and Conditions